Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Return on Invested Capital (2016 - 2022)

Edesa Biotech's Return on Invested Capital history spans 8 years, with the latest figure at 1.46% for Q2 2022.

  • For Q2 2022, Return on Invested Capital fell 18.0% year-over-year to 1.46%; the TTM value through Jun 2022 reached 1.46%, down 18.0%, while the annual FY2021 figure was 2.41%, 115.0% down from the prior year.
  • Return on Invested Capital for Q2 2022 was 1.46% at Edesa Biotech, up from 1.54% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.65% in Q4 2019 and bottomed at 1.64% in Q3 2021.
  • The 5-year median for Return on Invested Capital is 1.28% (2018), against an average of 1.23%.
  • The largest annual shift saw Return on Invested Capital crashed -68bps in 2018 before it decreased -18bps in 2022.
  • A 5-year view of Return on Invested Capital shows it stood at 1.29% in 2018, then surged by 50bps to 0.65% in 2019, then tumbled by -120bps to 1.42% in 2020, then fell by -15bps to 1.64% in 2021, then rose by 11bps to 1.46% in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Return on Invested Capital are 1.46% (Q2 2022), 1.54% (Q1 2022), and 1.64% (Q3 2021).